ConductScience.org, home

Paper8856046

Gangliosides block antigen presentation by human monocytes.

Heitger A and 1 other. Biochim Biophys Acta, 1996. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Gangliosides block antigen presentation by human monocytes. Papers, record 8856046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8856046

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gangliosides block antigen presentation by human monocytes.
PubMed
Journal
Biochim Biophys Acta
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2019-06-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heitger AA
2Ladisch SS

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigen PresentationMajor topic
GangliosidesMajor topic
Immunosuppressive AgentsMajor topic
MonocytesMajor topic
Antigens
Brain Chemistry
Humans
Lymphocyte Activation
Peptide Fragments
T-Lymphocyte Subsets
Tetanus Toxoid

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA42361NCI NIH HHSUnited StatesR01CA042361PubMed and NIHNIH RePORTER
CA61010NCI NIH HHSUnited StatesR01CA061010PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
39628991When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression.Front Oncol2024https://conductscience.org/library/papers/39628991PubMed
39051512Dysfunction of dendritic cells in tumor microenvironment and immunotherapy.Cancer Commun (Lond)2024https://conductscience.org/library/papers/39051512PubMed
35372499Role of Globotriaosylceramide in Physiology and Pathology.Front Mol Biosci2022https://conductscience.org/library/papers/35372499PubMed
33133075Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy.Front Immunol2020https://conductscience.org/library/papers/33133075PubMed
31874115Don't sugarcoat it: How glycocalyx composition influences cancer progression.J Cell Biol2020https://conductscience.org/library/papers/31874115PubMed
30761148The Role of Glycosphingolipids in Immune Cell Functions.Front Immunol2019https://conductscience.org/library/papers/30761148PubMed
29402391IFN-γ and tumor gangliosides: Implications for the tumor microenvironment.Cell Immunol2018https://conductscience.org/library/papers/29402391PubMed
28032600The function of cancer-shed gangliosides in macrophage phenotype: involvement with angiogenesis.Oncotarget2017https://conductscience.org/library/papers/28032600PubMed
26779443Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents.Front Oncol2015https://conductscience.org/library/papers/26779443PubMed
26226135GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.PLoS One2015https://conductscience.org/library/papers/26226135PubMed
24348482The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Front Immunol2013https://conductscience.org/library/papers/24348482PubMed
19276353GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells.Cancer Res2009https://conductscience.org/library/papers/19276353PubMed
17571260Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment.Cancer Immunol Immunother2007https://conductscience.org/library/papers/17571260PubMed
12902465Mechanisms of ganglioside inhibition of APC function.J Immunol2003https://conductscience.org/library/papers/12902465PubMed
12452834Gangliosides inhibit the development from monocytes to dendritic cells.Clin Exp Immunol2002https://conductscience.org/library/papers/12452834PubMed
12060764Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12060764PubMed
11982587Ganglioside expression in tissues of mice lacking beta2-microglobulin.Clin Exp Immunol2002https://conductscience.org/library/papers/11982587PubMed
10491412Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells.J Clin Invest1999https://conductscience.org/library/papers/10491412PubMed
9728328Sphingolipids and cell signalling.J Inherit Metab Dis1998https://conductscience.org/library/papers/9728328PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8856046

GET https://conductscience.org/api/papers/v1/8856046/authors